New hope for Drug-Resistant leukemia? experimental pill K0706 tested
Disease control
Terminated
This study tested an experimental drug called K0706 in people with chronic myeloid leukemia (CML) or a related blood cancer whose disease no longer responded to at least three other treatments. The goal was to see if the drug was safe and could shrink or control the cancer. The t…
Phase: PHASE1, PHASE2 • Sponsor: Sun Pharma Advanced Research Company Limited • Aim: Disease control
Last updated May 17, 2026 02:06 UTC